These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus. Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340 [TBL] [Abstract][Full Text] [Related]
4. Deficiency of T cell mediated regulation of anti-DNA production in systemic lupus erythematosus. Clough JD; Frank SA; Calabrese LH Arthritis Rheum; 1980 Jan; 23(1):24-9. PubMed ID: 6965452 [TBL] [Abstract][Full Text] [Related]
5. Class II major histocompatibility antigens and the etiology of systemic lupus erythematosus. Eisenberg RA; Cohen PL Clin Immunol Immunopathol; 1983 Oct; 29(1):1-6. PubMed ID: 6411402 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective. Moulton VR; Suarez-Fueyo A; Meidan E; Li H; Mizui M; Tsokos GC Trends Mol Med; 2017 Jul; 23(7):615-635. PubMed ID: 28623084 [TBL] [Abstract][Full Text] [Related]
8. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Jacob N; Stohl W Autoimmunity; 2010 Feb; 43(1):84-97. PubMed ID: 20014977 [TBL] [Abstract][Full Text] [Related]
9. Immune cells and cytokines in systemic lupus erythematosus: an update. Kyttaris VC; Juang YT; Tsokos GC Curr Opin Rheumatol; 2005 Sep; 17(5):518-22. PubMed ID: 16093827 [TBL] [Abstract][Full Text] [Related]
10. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE). Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929 [TBL] [Abstract][Full Text] [Related]
11. Cytokines play a central role in the pathogenesis of systemic lupus erythematosus. Singh AK Med Hypotheses; 1992 Dec; 39(4):356-9. PubMed ID: 1494323 [TBL] [Abstract][Full Text] [Related]
13. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077 [TBL] [Abstract][Full Text] [Related]
14. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus. Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427 [TBL] [Abstract][Full Text] [Related]
15. Aberrant B cell selection and activation in systemic lupus erythematosus. Kil LP; Hendriks RW Int Rev Immunol; 2013 Aug; 32(4):445-70. PubMed ID: 23768157 [TBL] [Abstract][Full Text] [Related]
16. T cells in the pathogenesis of systemic lupus erythematosus. Hoffman RW Clin Immunol; 2004 Oct; 113(1):4-13. PubMed ID: 15380523 [TBL] [Abstract][Full Text] [Related]
18. Prevention and control of reciprocal T-B cell diversification: implications for lupus-like autoimmunity. Singh RR Mol Immunol; 2004 Feb; 40(14-15):1137-45. PubMed ID: 15036920 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of systemic autoimmunity in murine models of SLE. Eisenberg R Immunol Res; 1998; 17(1-2):41-7. PubMed ID: 9479566 [TBL] [Abstract][Full Text] [Related]
20. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone. Murakami M; Kumagai S; Sugita M; Iwai K; Imura H Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]